Medicare Advantage is not a market where a carrier name, national reputation or one attractive local plan can tell the whole story. The same consumer-facing company can operate multiple Medicare contracts, offer different plans across counties and states, and change premiums, networks, prescription coverage and member costs from one plan year to the next. MarketReview's Medicare Advantage review process is designed around those differences rather than smoothing them into one national product that does not actually exist.
Our individual Medicare Advantage reviews evaluate the consumer-facing carrier as an editorial subject. That carrier-level perspective is useful for understanding the company's overall Medicare Advantage position, the types of plans and care models it brings to the market, how widely relevant it may be to shoppers and the recurring strengths or limitations that appear across its Medicare business. The final enrollment decision, however, remains plan-specific. A strong carrier rating does not mean every plan sold by that carrier will be a strong fit for every beneficiary.
We therefore keep two ideas separate throughout our work. The MarketReview Rating belongs to the Medicare Advantage carrier review. Premiums, deductibles, out-of-pocket limits, provider networks, drug formularies, Part B reductions and many other coverage details belong to exact plans in exact locations. That distinction affects how we research, write, rate and update every Medicare Advantage review.
What our Medicare Advantage reviews actually rate
MarketReview assigns one authoritative Medicare Advantage Rating to each reviewed consumer-facing carrier. The rating reflects our editorial assessment of that carrier within the Medicare Advantage market. It is not a CMS Star Rating, it is not a score for one CMS contract, and it is not a numerical average of every plan the company sells.
This carrier-level approach is deliberate. Consumers frequently begin with recognizable Medicare Advantage brands, and there are meaningful company-level differences worth evaluating. Carriers can differ in geographic reach, plan strategy, care model, access philosophy, the kinds of Medicare Advantage products they commonly offer and how consistently useful their plan portfolio appears across the markets we can verify.
At the same time, Medicare Advantage is too local and too plan-specific for us to turn a company rating into a promise about an individual plan. A carrier can have an excellent overall Medicare Advantage proposition while offering a plan in one county that does not include a reader's physician, places an important drug on an unfavorable tier or carries a higher out-of-pocket limit than a competing local option.
For that reason, the rating should be used as a research signal rather than an enrollment instruction. It can help identify carriers worth investigating, but the exact plan available at a beneficiary's address still needs its own comparison.
We separate the carrier, legal sponsor, CMS contract and exact plan
Medicare Advantage involves several layers of identity that are easy to collapse if the research process is not careful. MarketReview keeps those layers separate because they answer different questions.
The consumer-facing carrier is the name a shopper normally recognizes. That is the editorial object used for our individual carrier review and MarketReview Rating. Behind that brand can sit one or more legal Medicare organizations that sponsor contracts with the Centers for Medicare & Medicaid Services. Each CMS contract can contain multiple plan benefit packages, and an exact Medicare Advantage product can be identified by its contract, plan benefit package and segment.
Those distinctions matter. One carrier may operate under more than one CMS contract. Two plans carrying the same brand may have different service areas, premiums, drug coverage, cost sharing and provider arrangements. A legal contract sponsor can also differ from the consumer-facing company name used in advertising.
MarketReview does not flatten those identities into a single record. We preserve the consumer brand for editorial comparison while keeping legal sponsors, CMS contracts and exact plans distinct in the underlying canonical data. This allows a carrier review to discuss the broader company without falsely assigning one contract's facts to every plan sold under the brand.
It also protects against a common comparison error: treating two plans with the same logo as though they are interchangeable. They are not. The carrier relationship is useful context, but the exact plan identity controls the coverage a member actually receives.
Our research starts with current primary evidence
Medicare Advantage is a plan-year market, so our research gives priority to current primary sources. We do not rely on old plan summaries, stale comparison articles or a competitor's description when current official evidence is available.
Depending on the fact being verified, our research can include CMS Medicare Advantage datasets, official plan documents, Evidence of Coverage documents, Summary of Benefits documents, provider directories, formularies, pharmacy information, carrier Medicare pages and other authoritative plan materials.
Different sources answer different questions. CMS data is especially useful for canonical plan identity, contract information, plan type and other standardized Medicare records. A Summary of Benefits can provide a practical view of a specific plan's premium, medical cost sharing, out-of-pocket limits and major benefits. The Evidence of Coverage can provide additional detail about member responsibilities, exclusions, prior authorization, network rules and the operation of benefits.
We prefer the most specific reliable source available for the claim being made. A carrier's general Medicare Advantage marketing page can establish that the company offers a particular type of product, but it is not sufficient evidence for a specific local plan's deductible or out-of-pocket limit. Those figures require plan-specific evidence.
Secondary sources can help identify issues worth investigating, but they do not replace primary authority for consequential plan facts. If an outside article and an official plan document disagree, we investigate the underlying primary evidence rather than choosing whichever number is more convenient.
Plan year and location are part of the fact
Medicare Advantage information is time-sensitive. A premium, benefit, network or out-of-pocket limit verified for one plan year should not silently become an evergreen statement about the plan or carrier.
MarketReview therefore treats plan year as part of the evidence. When a fact belongs to an exact annual plan snapshot, we preserve it that way. A plan can change its premium, medical deductible, Part B reduction, prescription deductible, hospital cost sharing, supplemental benefits or service area in a later year.
Geography is equally important. Medicare Advantage availability depends on service area. A plan sold in one county may not be available in the next county, even when both are served by the same carrier. The same company can also offer very different plan designs across states and regions.
That is why our carrier reviews avoid national statements such as saying that a company has one universal premium, one deductible or one out-of-pocket maximum. Those are normally exact-plan facts. When we discuss a specific plan as an example, we identify it as a specimen rather than implying that its terms apply to the carrier everywhere.
This distinction also affects Best pages and Compare. A carrier may qualify for a Best page because we have verified a relevant local plan example, such as a $0-premium plan, a Part B giveback plan or a plan with a comparatively low out-of-pocket limit. The existence of that example does not mean every plan from the carrier has the same feature.
Provider access is evaluated separately from carrier size
A large Medicare Advantage company does not automatically have the best provider access for every shopper. Carrier size, state presence and plan count can make a company more relevant to more people, but the provider network of the exact plan remains the more important enrollment fact.
Our reviews consider the carrier's general access model and the kinds of network structures it uses where that can be verified safely. We distinguish between integrated care organizations, carriers offering multiple network designs and regional insurers whose value may come from strong local relationships rather than national scale.
We do not assume that a doctor who accepts one plan from a carrier accepts every plan from that company. Provider participation can differ by product and service area. We also do not treat the statement that a provider accepts Medicare as confirmation that the provider participates with a specific Medicare Advantage plan.
PPO plans receive particular care because out-of-network coverage can be misunderstood. A PPO can generally provide more flexibility than an HMO, but out-of-network care can cost more and a noncontracted provider may not always be required to accept the plan for routine care. We therefore avoid describing PPO access as unrestricted provider choice.
For consumers comparing exact plans, we recommend confirming important doctors, specialists and hospitals directly against the current plan rather than relying on the carrier's general reputation for network size.
Prior authorization and referrals are treated as different issues
Referral requirements and prior authorization are not interchangeable. A plan may allow a member to see a specialist without obtaining a referral from a primary-care physician while still requiring prior authorization before certain procedures, scans, therapies, drugs or medical equipment are covered.
Our reviews keep those concepts separate. When reliable evidence supports a general carrier or plan-type pattern, we can explain it, but authorization requirements remain highly plan- and service-specific.
We pay particular attention to prior authorization when it could materially affect access to expensive or recurring care. That can include advanced imaging, rehabilitation, home health, durable medical equipment, specialty treatment and other services where approval requirements can shape the member experience.
We do not reduce prior authorization to a simplistic good-or-bad label. Utilization management exists across Medicare Advantage, and the relevant consumer question is whether the exact plan's rules are workable for the care the member expects to use.
When plan documents do not support a carrier-wide conclusion, we do not manufacture one. The review explains the limitation and leaves the exact authorization question to the plan-level comparison.
We evaluate costs as a system rather than focusing on the premium
Medicare Advantage cost comparisons can become misleading when the monthly plan premium receives too much attention. A $0-premium plan can still expose a member to substantial costs through specialist visits, hospital care, outpatient services, medical deductibles, prescription coverage and the annual out-of-pocket limit.
Our research therefore separates fixed monthly cost from the costs that arise when care is used. Where exact plan examples are discussed, we distinguish the plan premium from the Medicare Part B premium, and we treat Part B premium reductions as a separate benefit rather than another way of describing a $0 plan premium.
We also distinguish between the medical deductible and the Part D prescription deductible. They are not the same cost. The medical maximum out-of-pocket limit applies to covered Part A and Part B services, while prescription drug spending follows the Part D cost structure.
For PPOs, we keep the in-network medical out-of-pocket limit separate from any combined in-network and out-of-network limit. A plan can have an attractive in-network ceiling while exposing members who regularly leave the network to a higher combined limit.
Our editorial assessment looks for evidence that the carrier offers plans capable of delivering competitive value, but we do not assign one local premium or one out-of-pocket maximum to the carrier as a whole. Those numbers stay attached to the exact plan where they were verified.
Prescription coverage is reviewed independently from medical coverage
Most Medicare Advantage plans include Part D prescription drug coverage, but a strong medical network does not guarantee a strong prescription benefit for a particular member.
Formularies, drug tiers, preferred pharmacies, deductibles, prior authorization, quantity limits and step therapy can vary between plans. Two plans from the same carrier can therefore produce materially different prescription costs for the same beneficiary.
MarketReview does not treat one formulary as a carrier-wide formulary. When prescription coverage is discussed in a carrier review, we focus on the carrier's broader Medicare Advantage role while making clear that medication coverage must be confirmed against the exact plan.
This is especially important for beneficiaries who take specialty medications or several ongoing prescriptions. A plan that performs well on premium and medical cost sharing can still be a poor fit if one important drug is covered unfavorably.
Our methodology therefore treats medical access and prescription access as related but distinct parts of the Medicare Advantage decision. Both need to work before a plan can be considered a strong fit for an individual member.
CMS Star Ratings and MarketReview Ratings remain separate
CMS Star Ratings are an important source of Medicare quality information, but they are not the same thing as MarketReview Ratings.
CMS Star Ratings are tied to Medicare contracts and rating years. A consumer-facing carrier can operate multiple Medicare contracts, and those contracts can have different CMS rating histories. We do not convert one contract's CMS rating into a universal score for the carrier.
MarketReview Ratings are editorial assessments created for our consumer-facing Medicare Advantage reviews. They can consider verified quality evidence where relevant, including CMS information, but they also consider aspects of the shopping decision that are not represented by simply copying a CMS Star Rating.
We never relabel a CMS Star Rating as a MarketReview Rating, and we never imply that MarketReview produced a government quality score. The two systems remain visibly and conceptually distinct.
This matters across our site. A carrier's MarketReview Rating should remain consistent on its individual Review, the Reviews Hub, Compare and Best pages. Best For labels and ranking positions can change depending on the page's shopping intent, but the underlying carrier rating should not change simply because the topic changes.
How we form and maintain a MarketReview Rating
Our Medicare Advantage Rating is an editorial judgment supported by verified evidence. We do not present a fake mathematical formula, invent percentage weights or claim that a mechanical score can capture every Medicare Advantage tradeoff.
We consider the quality and usefulness of the carrier's Medicare Advantage proposition, the plan structures we can verify, access model, geographic relevance, evidence of practical cost options, prescription integration, quality evidence and meaningful limitations. The relative importance of those factors is judged in context rather than reduced to a rigid public formula.
The rating rationale is maintained as part of the editorial review record. The visible article explains the evidence and tradeoffs without repeatedly defending the numerical score in every section.
Ratings can change when the underlying evidence changes materially. A carrier can expand or contract its Medicare Advantage presence, alter its plan strategy, change important access arrangements, experience a meaningful shift in quality evidence or introduce plan designs that change our view of its overall consumer proposition.
We do not change a rating merely because one local plan raises or lowers a copay. Carrier ratings should respond to meaningful evidence at the carrier-review level, while plan-specific changes remain attached to the affected plan.
When evidence becomes stale or cannot be reconfirmed, we do not treat an old verified fact as permanently current. Medicare Advantage requires ongoing plan-year review precisely because the product can change substantially from one enrollment cycle to the next.
How Reviews, Best pages and Compare work together
MarketReview uses different commercial surfaces for different stages of the decision. They share the same underlying rating authority but do not perform the same job.
An individual Medicare Advantage Review examines one carrier in depth. It explains the carrier's Medicare Advantage position, strengths, limitations, care model, evidence and the questions a shopper should resolve at the exact-plan level.
The Reviews Hub organizes those individual carrier reviews. It is designed for shoppers who want to research one company or move among several carrier reviews before narrowing the field.
Best pages answer narrower shopping questions. The flagship page may emphasize overall Medicare Advantage strength. A PPO page emphasizes provider flexibility. A $0-premium page emphasizes evidence of plans with no additional plan premium. A Part B giveback page emphasizes verified premium reductions. A low-out-of-pocket page emphasizes exact plan examples with lower medical ceilings.
Because the shopping question changes, the ranking order and Best For labels can change. The underlying MarketReview carrier rating does not.
The standalone Compare page serves another purpose. It lets shoppers place carriers side by side using carrier-level information that can be compared safely without pretending the page is a ZIP-code quote engine. After the carrier shortlist is built, the consumer still needs to compare the exact plans available locally.
What MarketReview deliberately does not claim
There are limits to what a national Medicare Advantage carrier review can tell an individual beneficiary, and we consider it important to make those limits explicit.
We do not claim that one carrier has one national premium, deductible, out-of-pocket maximum, provider network or drug formulary. We do not assume that every doctor who works with a carrier participates in every plan. We do not assume that a benefit verified in one county is available in another. We do not convert one CMS contract's Star Rating into a company-wide quality score.
We also do not treat the carrier with the highest MarketReview Rating as the automatic choice for every person. A lower-rated carrier can offer the better exact plan for a particular beneficiary when the local network, medications, cost sharing and benefits fit more closely.
MarketReview does not replace Medicare's enrollment tools, current carrier plan documents, provider confirmation or formulary checks. Our role is to make the research process clearer, identify meaningful differences and help shoppers know what deserves verification before enrollment.
The final Medicare Advantage decision should always be made at the exact-plan level. Confirm the plan year and service area, check important providers and hospitals, review prescriptions, examine premiums and medical cost sharing, compare the applicable out-of-pocket limit, and verify any extra benefit that materially affects the decision.
A strong review should leave a reader with a better shortlist and better questions, not with the impression that a national carrier rating can substitute for checking the plan they will actually enroll in.